Short answer: what a pharma plant costs in India in 2026 The pharma manufacturing plant cost in India runs from roughly ₹5–15 crore for a small oral-solids unit, ₹50–80 crore for a mid-scale multi-formulation export-capable facility, and ₹170–355 crore for…
Tablet compression machines, also known as tablet presses, are precision pharmaceutical manufacturing equipment designed to transform carefully formulated powders or granulated materials into tablets of uniform size, shape, weight, and hardness. These machines operate according to Pascal’s Law and the principles of hydraulic…
In pharmaceutical manufacturing, selecting a tablet compression machine that meets USFDA and EU GMP standards ensures consistent tablet quality, high throughput, and seamless regulatory compliance. These top five models—Fette Compacting FE55, Korsch AG XL 400 (4th Generation), GEA NexGen Press…
We arranged all questions from the trending interviews organised in the recent months in different pharmaceutical companies in the region based on the feedback of candidates who appeared in those interviews. If you are planning to attending an interview in…
India’s pharmaceutical sector offers immense opportunities, but selecting the right business model—PCD, Third-Party, or Own Plant—can make or break your startup. This guide breaks down each model’s pros, cons, and strategic fit to help you decide.
Planning to set up a pharmaceutical plant? This comprehensive guide lists all essential machinery for tablet, capsule, and liquid manufacturing sections, complete with vendor links, price ranges, and FAQs. Ideal for startups, plant buyers, and technical heads looking to make informed decisions. Save time and money with trusted vendor recommendations and compliance tips!
Purchasing a pharmaceutical company is a significant investment decision that requires a thorough valuation to ensure a successful and profitable decision. In this blog post, we will explore the importance of valuation, key factors to consider, the role of experts,…
Establishing a new pharmaceutical manufacturing facility in India is a capital-intensive and time-consuming endeavor, often requiring investments upwards of ₹5-6 crores and navigating complex regulatory approvals. For entrepreneurs and established companies alike, renting or leasing a pre-existing, certified pharma unit…
For pharmaceutical manufacturers in India, complying with Schedule M – the cornerstone of Good Manufacturing Practices (GMP) – has long been the game. But the winds of change have blown, ushering in a revised Schedule M, promising a more robust…
NPPA issued a list of 29 Formulations in October 2023 National Pharmaceutical Pricing Authority (NPPA) passed an Order S.O. 4660(E) (E) on 25th October 2023. In this order, NPPA revised the ceiling price of 29 formulations at the request of several…